Re: Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products.
Prev Med
; 120: 158-159, 2019 03.
Article
en En
| MEDLINE
| ID: mdl-30738502
ABSTRACT
This Letter to the Editor is in response to a letter from Ms. Flannery, titled, "Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products". In our response, we address some concerns raised by Ms. Flannery, and reiterate our position in our original article. In particular, we underline the importance of a rational public health calculus that weighs beneficial and harmful consequences of policies related to noncombustible nicotine product (NNP) use. We further emphasize the need to correct misperceptions about relative risk of different products to encourage smokers to switch to NNPs. Lastly, we are explicit about our assertion that no use of any nicotine-containing products is the only way to avoid harm at any age, but that we must view this issue pragmatically for the benefit of public health.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Productos de Tabaco
/
Sistemas Electrónicos de Liberación de Nicotina
Tipo de estudio:
Etiology_studies
/
Health_economic_evaluation
Límite:
Humans
Idioma:
En
Revista:
Prev Med
Año:
2019
Tipo del documento:
Article